4-82-725
| 规格 | 目录价格 | 上海 | 安徽 | 武汉 | 成都 | 北方 | 深圳 | 会员价格 | 数量 |
|---|---|---|---|---|---|---|---|---|---|
| g | ￥ ȨůľƔƔ | > | > | -- | -- | -- | -- | ￥ ȨůľƔƔ | - + |
| 5g | ￥ ƊƵľƔƔ | > | > | -- | -- | -- | -- | ￥ ƊƵľƔƔ | - + |
| g | ￥ ǫƔľƔƔ | > | 5 | 4 | 2 | ￥ ǫƔľƔƔ | - + | ||
| 25g | ￥ ʼnʼnľƔƔ | 4 | > | 5 | 8 | 5 | ￥ ʼnʼnľƔƔ | - + | |
| g | ￥ ƊʼnůľƔƔ | > | 4 | 6 | 2 | ￥ ƊʼnůľƔƔ | - + | ||
| 5g | ￥ ƵǣʼnȐľƔƔ | -- | 5 | -- | ￥ ƵǣʼnȐľƔƔ | - + | |||
| g | 请询价 | -- | -- | -- | -- | -- | -- | -- | - + |
| 大货 | 请询价 | -- | -- | -- | -- | -- | -- | -- | - + |
9.2
[]. Mark Johnson, et al. Structure-activity relationship study of N?-(2-(4-(H-Indol-5-yl)piperazin--yl)ethyl)-N?-propyl-4,5,6,7-tetrahydrobenzo[d]thiazole-2,6-diamine analogues: development of highly selective D dopamine receptor agonists along with a highly potent D2/D agonist and their pharmacological characterization. J Med Chem. 22 Jun 28;55(2):5826-4.
H227-H5-H9-H5
P2-P26-P264-P27-P28-P2+P52-P4+P4-P62+P64-P7+P78-P4-P45-P5
GHS7
74962 现货
￥ ȨůľƔƔ -5g
272 现货
￥ ƊƊľƔƔ -25mg
675 现货
￥ ȨůľƔƔ -g
29445 现货
￥ ƊƔľƔƔ -5g
5697 现货
￥ ƊɄľƔƔ -25mg
245 现货
￥ ʼnƊľƔƔ -mg
2225 现货
￥ ƊȨľƔƔ -25mg
22558 现货
￥ ůʼnľƔƔ -g
24888 货期咨询
7697 货期咨询
￥ ǣƔľƔƔ -25mg
沪ICP备79645号
